BioProgress launches two new dosage products in US

Published: 21-Dec-2006


UK-based speciality pharma and healthcare company, BioProgress has launched two new products in the US through its subsidiary Dexo LLC. It has also placed its first production Tab-Wrap system into a fully compliant pharmaceutical manufacturing facility.

The first product is the launch of a twice-a-day formulation of its Ah-Chew II chewable tablet. The previous formulation was a four-times-a-day dosage.

The second product is the EZ Spacer Hero Kit, aimed at the paediatric market. This is a portable drug delivery system designed for use with most metered dose inhalers. The E-Z Spacer is novel in that it has a visual sign when treatment is completed as the clear reservoir bag collapses when medication has been inhaled. This make it ideal for paediatric use and offers an alternative to the established fixed volume systems, says the company.

Dexo is also planning to launch two further products in 2007.

Meanwhile, a system for producing TabWrap, the company's novel tablet coating technology, has been placed with Inyx Group at its site near Manchester, England. Inyx, is a specialty pharmaceutical company with niche drug-delivery technologies and products for the treatment of respiratory, allergy, dermatological, topical and cardiovascular conditions.

BioProgress will commence its validation programme of the system at the new site early in 2007 with products being put onto stability programmes using the technology for BioProgress's own product developments and for third party product development partners.

You may also like